One-liner#
Monitoring requirements are a common cause of adverse events and denials—standardize them.
High-yield categories to track#
- Antihypertensives/diuretics (electrolytes/renal function as appropriate)
- Diabetes meds (A1c cadence; renal function for some agents)
- Statins (baseline and symptom-driven monitoring per policy)
- Anticoagulants/antiplatelets (indication, renal dosing when relevant, bleeding risk)
- NSAIDs (renal/GI/CV risk; avoid chronic use in high-risk patients)
Documentation checklist#
- Indication and intended duration (especially for “bridge” meds)
- Monitoring plan and target parameters
- Safety counseling (side effects, red flags, when to stop/seek care)